Article Versions Notes

Bragina O, Chernov V, Larkina M, Varvashenya R, Zelchan R, Medvedeva A, Ivanova A, Tashireva L, Maina T, Nock BA, et al. The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [^99mTc]Tc-DB8. Pharmaceutics. 2025; 17(8):1000. https://doi.org/10.3390/pharmaceutics17081000

Bragina, Olga, Vladimir Chernov, Mariia Larkina, Ruslan Varvashenya, Roman Zelchan, Anna Medvedeva, Anastasiya Ivanova, Liubov Tashireva, Theodosia Maina, Berthold A. Nock, and et al. 2025. "The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [^99mTc]Tc-DB8" Pharmaceutics 17, no. 8: 1000. https://doi.org/10.3390/pharmaceutics17081000

Bragina, O., Chernov, V., Larkina, M., Varvashenya, R., Zelchan, R., Medvedeva, A., Ivanova, A., Tashireva, L., Maina, T., Nock, B. A., Kanellopoulos, P., Sörensen, J., Orlova, A., & Tolmachev, V. (2025). The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [^99mTc]Tc-DB8. Pharmaceutics, 17(8), 1000. https://doi.org/10.3390/pharmaceutics17081000